ID
35818
Description
Study ID: 103860-115 Clinical Study ID: 103860-115 Study Title: Immunogenicity and protective efficacy of GlaxoSmithKline (previously SmithKlineBeecham) Biologicals’ hepatitis B vaccine (10mcg) in newborn of HBeAg and HBsAg positive mothers compared with a historical control group. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: N/A Study Indication: Hepatitis B
Keywords
Versions (2)
- 3/25/19 3/25/19 -
- 12/27/19 12/27/19 -
Copyright Holder
GSK group of companies
Uploaded on
March 25, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Hepatitis B vaccine in newborn of HBeAg and HBsAg positive mothers - 103860-115
Long Term Follow-Up
- StudyEvent: ODM
Description
BLOOD SAMPLING
Description
DEMOGRAPHICS
Description
LABORATORY TESTS
Description
INVESTIGATOR SIGNATURE
Description
Long Term Follow-Up (Year 15)
Description
BLOOD SAMPLING
Description
DEMOGRAPHICS
Description
LABORATORY TESTS
Description
INVESTIGATOR SIGNATURE
Similar models
Long Term Follow-Up
- StudyEvent: ODM